Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.
Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.
复制标题
DOI:
10.1016/j.jamcollsurg.2015.12.006
复制
发表时间:
2016-06
影响因子:
5.2
通讯作者:
Hodin RA
中科院分区:
文献类型:
--
作者:
Liu W;Hu D;Huo H;Zhang W;Adiliaghdam F;Morrison S;Ramirez JM;Gul SS;Hamarneh SR;Hodin RA
Intestinal alkaline phosphatase (IAP) plays a pivotal role in maintaining gut health and well-being. Oral supplementation with IAP in mice improves gut barrier function and prevents luminal proinflammatory factors from gaining access to the circulation. In this study, we sought to explore the relationship between IAP and tight junction protein (TJP) expression and function. The effect of IAP deletion on TJP levels was studied in mouse embryonic fibroblasts (MEFs) generated from IAP-knockout and wild type mice. Regulation of TJPs by IAP was assayed in the human colon cancer Caco-2 and T84 cells by overexpressing the human IAP gene. Tight junction protein levels and localization were measured by using RT q-PCR and antibodies targeting the specific TJPs. Finally, the effect of IAP on inflammation-induced intestinal permeability was measured by in vitro trans-well epithelial electrical resistance (TEER). Intestinal alkaline phosphatase gene deletion in MEFs resulted in significantly lower levels of ZO-1, ZO-2, and Occludin compared with levels in wild-type control cells; IAP over-expression in Caco-2 and T84 cells resulted in approximate 2-fold increases in the mRNA levels of ZO-1 and ZO-2. The IAP treatment ameliorated lipopolysaccharide-induced increased permeability in the Caco-2 trans-well system. Furthermore, IAP treatment preserved the localization of the ZO-1 and Occludin proteins during inflammation and was also associated with improved epithelial barrier function. Intestinal alkaline phosphatase is a major regulator of gut mucosal permeability and appears to work at least partly through improving TJP levels and localization. These data provide a strong foundation to develop IAP as a novel therapy to maintain gut barrier function.
登录
查看更多内容
影响因子:
2.4
作者:
Bischoff SC;Barbara G;Buurman W;Ockhuizen T;Schulzke JD;Serino M;Tilg H;Watson A;Wells JM
通讯作者:
Wells JM
影响因子:
4.9
作者:
Ramasamy, Sundaram;Nguyen, Deanna D.;Eston, Michelle A.;Alam, Sayeda Nasrin;Moss, Angela K.;Ebrahimi, Farzad;Biswas, Brishti;Mostafa, Golam;Chen, Kathryn T.;Kaliannan, Kanakaraju;Yammine, Halim;Narisawa, Sonoko;Millan, Jose Luis;Warren, H. Shaw;Hohmann, Elizabeth L.;Mizoguchi, Emiko;Reinecker, Hans-Christian;Bhan, Atul K.;Snapper, Scott B.;Malo, Madhu S.;Hodin, Richard A.
通讯作者:
Hodin, Richard A.
DOI:
10.1093/gerona/glt106
发表时间:
2013-09-01
影响因子:
5.1
作者:
Lee Tran;Greenwood-Van Meerveld, Beverley
通讯作者:
Greenwood-Van Meerveld, Beverley
DOI:
10.1073/pnas.1220180110
发表时间:
2013-04-23
影响因子:
11.1
作者:
Kaliannan, Kanakaraju;Hamarneh, Sulaiman R.;Hodin, Richard A.
通讯作者:
Hodin, Richard A.
影响因子:
6
作者:
Guo, Shuhong;Al-Sadi, Rana;Ma, Thomas Y.
通讯作者:
Ma, Thomas Y.